Monocyte Chemotactic Protein-1 (MCP-1), -2, and -3 Are Chemotactic for Human T Lymphocytes

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1995 Mar 1

PMID 7883984

Citations 83

Authors

D D Taub

P Proost

W J Murphy

M Anver

D L Longo

J Van Damme

J J Oppenheim

Affiliations

Soon will be listed here.

Abstract

Monocyte chemotactic protein (MCP)-1, -2, and -3 all have been shown to induce monocyte/macrophage migration in vitro and MCP-1, also known as MCAF, chemoattracts basophils and mast cells. We report here that natural MCP-1 as well as synthetic preparations of MCP-2 and MCP-3 stimulate significant in vitro chemotaxis of human peripheral blood T lymphocytes. This MCP-induced migration was dose-dependent and directional, but not chemokinetic. Phenotypic analysis of the T cell population responsive to MCP-1, MCP-2, and MCP-3 demonstrates that both CD4+ and CD8+ T cells migrated in response to these chemokines. Similar results were observed using human CD4+ and CD8+ T cell clones. Neutralizing antisera to MCAF or MCP-2 abrogated T cell migration in response to MCP-1 and MCP-2, respectively, but not to RANTES. Subcutaneous administration of purified MCP-1 into the hind flanks of SCID mice engrafted with human peripheral blood lymphocytes (PBL) induced significant human CD3+ T cell infiltration into the site of injection at 4 h. These results demonstrate that MCP-1, MCP-2, and MCP-3 are inflammatory mediators that specifically stimulate the directional migration of T cells as well as monocytes and may play an important role in immune cell recruitment into sites of antigenic challenge.

Citing Articles

Differentiating Latent Tuberculosis from Active Tuberculosis Through Activation Phenotypes and Chemokine Markers HLA-DR, CD38, MCP-1, and RANTES: A Systematic Review and Meta-Analysis.

Kadi C, Ahmadi N, Houdou A, Badisy I, Bouaddi O, Mennane Z Biomark Insights. 2025; 20():11772719241312776.

PMID: 39802700 PMC: 11713980. DOI: 10.1177/11772719241312776.

ONDSA: a testing framework based on Gaussian graphical models for differential and similarity analysis of multiple omics networks.

Chen J, Murabito J, Lunetta K Brief Bioinform. 2024; 26(1).

PMID: 39581869 PMC: 11586129. DOI: 10.1093/bib/bbae610.

Using Hybrid Nanoplatforms to Combine Traditional Anti-Inflammatory Drug Delivery with RNA-Based Therapeutics for Macrophage Reprograming.

Almeida A, Miranda M, Reis R, Gomes M, Rodrigues M Int J Mol Sci. 2024; 25(19).

PMID: 39409023 PMC: 11476774. DOI: 10.3390/ijms251910693.

Sinomenine protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting of inflammatory pathway.

Gao Z, Yang C, Zeng G, Lin M, Li W, Sun M Inflammopharmacology. 2024; 32(2):1387-1400.

PMID: 38430414 DOI: 10.1007/s10787-024-01437-8.

Human inherited CCR2 deficiency underlies progressive polycystic lung disease.

Neehus A, Carey B, Landekic M, Panikulam P, Deutsch G, Ogishi M Cell. 2023; 187(2):390-408.e23.

PMID: 38157855 PMC: 10842692. DOI: 10.1016/j.cell.2023.11.036.

References

Yoshimura T, Yuhki N, Moore S, Appella E, Lerman M, Leonard E . Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989; 244(2):487-93. DOI: 10.1016/0014-5793(89)80590-3. View

Van Damme J, Decock B, Lenaerts J, Conings R, Bertini R, Mantovani A . Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur J Immunol. 1989; 19(12):2367-73. DOI: 10.1002/eji.1830191228. View

Schall T . Biology of the RANTES/SIS cytokine family. Cytokine. 1991; 3(3):165-83. DOI: 10.1016/1043-4666(91)90013-4. View

Oppenheim J, Zachariae C, Mukaida N, Matsushima K . Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991; 9:617-48. DOI: 10.1146/annurev.iy.09.040191.003153. View

Kuna P, Reddigari S, Rucinski D, Oppenheim J, Kaplan A . Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992; 175(2):489-93. PMC: 2119123. DOI: 10.1084/jem.175.2.489. View

Alam R, Forsythe P, Kenamore C, Kormos C, Grant J . Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest. 1992; 89(3):723-8. PMC: 442914. DOI: 10.1172/JCI115648. View

Matsushima K, Baldwin E, Mukaida N . Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol. 1992; 51:236-65. View

Van Damme J, Proost P, Lenaerts J, Opdenakker G . Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med. 1992; 176(1):59-65. PMC: 2119277. DOI: 10.1084/jem.176.1.59. View

Bischoff S, Krieger M, Brunner T, Rot A, Von Tscharner V, Baggiolini M . RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol. 1993; 23(3):761-7. DOI: 10.1002/eji.1830230329. View

10.

Opdenakker G, Froyen G, Fiten P, Proost P, Van Damme J . Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun. 1993; 191(2):535-42. DOI: 10.1006/bbrc.1993.1251. View

11.

Taub D, Conlon K, Lloyd A, Oppenheim J, Kelvin D . Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993; 260(5106):355-8. DOI: 10.1126/science.7682337. View

12.

Taub D, Lloyd A, Conlon K, Wang J, Ortaldo J, Harada A . Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993; 177(6):1809-14. PMC: 2191047. DOI: 10.1084/jem.177.6.1809. View

13.

Schall T, Bacon K, Camp R, Kaspari J, Goeddel D . Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med. 1993; 177(6):1821-6. PMC: 2191042. DOI: 10.1084/jem.177.6.1821. View

14.

Taub D, Oppenheim J . Review of the chemokine meeting the Third International Symposium of Chemotactic Cytokines. Cytokine. 1993; 5(3):175-9. DOI: 10.1016/1043-4666(93)90001-l. View

15.

Wang J, Hishinuma A, Oppenheim J, Matsushima K . Studies of binding and internalization of human recombinant monocyte chemotactic and activating factor (MCAF) by monocytic cells. Cytokine. 1993; 5(3):264-75. DOI: 10.1016/1043-4666(93)90014-v. View

16.

Sozzani S, Zhou D, Locati M, Rieppi M, Proost P, Magazin M . Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol. 1994; 152(7):3615-22. View

17.

CARR M, Roth S, Luther E, ROSE S, Springer T . Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994; 91(9):3652-6. PMC: 43639. DOI: 10.1073/pnas.91.9.3652. View

18.

Van Damme J, Proost P, Put W, Arens S, Lenaerts J, Conings R . Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol. 1994; 152(11):5495-502. View

19.

Murphy W, Taub D, Anver M, Conlon K, Oppenheim J, Kelvin D . Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency. Eur J Immunol. 1994; 24(8):1823-7. DOI: 10.1002/eji.1830240815. View

20.

Matsushima K, Larsen C, DuBois G, Oppenheim J . Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 1989; 169(4):1485-90. PMC: 2189236. DOI: 10.1084/jem.169.4.1485. View